Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.5.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JG.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.1.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JF.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HL.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.42.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DZ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.14.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DY.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.14.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.14.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DY.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.48EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.49EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.14.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GY.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.57EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.59EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.24.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.17.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.63EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.14.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.13.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GE.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.93EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GM.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.13.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used